Novo Nordisk, Ozempics maker, is working with health authorities
BMI over 30, or over 27 with metabolic risk factors History of weight loss followed by regain Concerns about muscle loss during weight reduction Signs of age-related growth hormone decline Commitment to dietary and exercise optimization alongside peptide use Understanding of research compound status and associated considerations Those specifically concerned about muscle preservation during weight loss make particularly appropriate candidates for the combined protocol
Gut Health & Inflammation Testing Advanced microbiome and inflammation panels reveal underlying causes of bloating, fatigue, or slow metabolism so we can target the root, not just the symptom
Some prefer taking it in the morning on an empty stomach, while others choose night-time for recovery and repair benefits
CONCLUSIONS Ethics statements Not applicable
That is because at TrimBody M.D., we address the issues behind your inability to lose weight and address those specific issues on an individual basis